Hans Olivecrona
Chief Tech/Sci/R&D Officer at KLARIA PHARMA HOLDING AB
Profile
Hans Olivecrona is currently the Chief Medical Officer at Klaria Pharma Holding AB since 2022.
Prior to this, he worked as the Senior Medical Director at Swedish Orphan Biovitrum AB.
From 2017 to 2020, he was the Chief Medical Officer at PCI Biotech Holding ASA. He also held the position of Chief Medical Officer at Immedica Pharma AB.
Dr. Olivecrona obtained his doctorate degree from Karolinska Institutet.
Hans Olivecrona active positions
Companies | Position | Start |
---|---|---|
KLARIA PHARMA HOLDING AB | Chief Tech/Sci/R&D Officer | 2022-02-28 |
Former positions of Hans Olivecrona
Companies | Position | End |
---|---|---|
PCI BIOTECH HOLDING ASA | Chief Tech/Sci/R&D Officer | 2020-04-30 |
Immedica Pharma AB
Immedica Pharma AB Pharmaceuticals: MajorHealth Technology Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden. | Chief Tech/Sci/R&D Officer | - |
SWEDISH ORPHAN BIOVITRUM AB | Chief Tech/Sci/R&D Officer | - |
Training of Hans Olivecrona
Karolinska Institutet | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
PCI BIOTECH HOLDING ASA | Health Technology |
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
KLARIA PHARMA HOLDING AB | Health Technology |
Private companies | 1 |
---|---|
Immedica Pharma AB
Immedica Pharma AB Pharmaceuticals: MajorHealth Technology Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden. | Health Technology |
- Stock Market
- Insiders
- Hans Olivecrona